Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Factors associated with benign multiple sclerosis in the New York State MS Consortium (NYSMSC).
ON THE CONTRIBUTION OF THE PHAGOCYTOSIS AND THE SOLUBILIZATION TO THE IRON OXIDE NANOPARTICLES RETENTION IN AND ELIMINATION FROM LUNGS UNDER LONG-TERM INHALATION EXPOSURE.
Low-intensity pulsed ultrasound upregulates pro-myelination indicators of Schwann cells enhanced by co-culture with adipose-derived stem cells.
AVN-101: A Multi-Target Drug Candidate for the Treatment of CNS Disorders.
Effects of Chronic Scopolamine Treatment on Cognitive Impairments and Myelin Basic Protein Expression in the Mouse Hippocampus.
The use of clinically approved small particles of iron oxide (SPIO) for labeling of mesenchymal stem cells aggravates clinical symptoms in experimental autoimmune encephalomyelitis and influences their in vivo distribution.
Analysis of clinical outcomes according to original treatment groups 16 years after the pivotal IFNB-1b trial.
Intervention modalities for targeting cognitive-motor interference in individuals with neurodegenerative disease: a systematic review.
Aptamer and its applications in neurodegenerative diseases.
Chronic inflammatory demyelinating polyneuropathy variant (Lewis- Sumner syndrome) in HIV.
Poster 11 A Rare Case of Chronic Inflammatory Demyelinating Polyneuropathy in the Setting of SLE: A Case Report.
Cooccurrence of Multiple Sclerosis and Idiopathic Basal Ganglia Calcification.
Differential Effects of Stress on Microglial Cell Activation in Male and Female Medial Prefrontal Cortex.
MHC haplotype-dependent regulation of MOG-induced EAE in rats.
Associations of HLA DRB1 alleles with IgG oligoclonal bands and their influence on multiple sclerosis course and disability status.
Immune responses to polyclonal T-cell vaccination in patients with progressive multiple sclerosis.
Autophagy induction stabilizes microtubules and promotes axon regeneration after spinal cord injury.
Adenosine A1-Receptors Modulate mTOR Signaling to Regulate White Matter Inflammatory Lesions Induced by Chronic Cerebral Hypoperfusion.
Calpain Inhibition Reduces Structural and Functional Impairment of Retinal Ganglion Cells in Experimental Optic Neuritis.
Differential diagnosis, discerning depression from cognition.
Neuroimmune mechanisms in Krabbe's disease.
Capturing the worlds of multiple sclerosis: Hannah Laycock's photography.
Explaining fatigue in multiple sclerosis: cross-validation of a biopsychosocial model.
An unusual infection in MS patient treated with dimethyl fumarate: A case report of omphalitis.
Health insurance affects the use of disease-modifying therapy in multiple sclerosis.
Pages
« first
‹ previous
…
741
742
743
744
745
746
747
748
749
…
next ›
last »